New York · 2025 Regular Session · Bill

A 7501: Adds tianeptine sodium to the list of Schedule II of controlled substances

In committee Last action January 7, 2026: REFERRED TO HEALTH

Plain-language summary

A 7501 is a bill introduced in the New York House on March 28, 2025. According to its official title, it concerns: Adds tianeptine sodium to the list of Schedule II of controlled substances. Primary sponsor: Ed Braunstein (Democratic). Most recent recorded action (January 7, 2026): REFERRED TO HEALTH.

Sponsors

Primary sponsor: Ed Braunstein (Democratic).